(Q37610425)

21 August 2017

1 reference

title

AGE and their receptor RAGE in systemic autoimmune diseases: an inflammation propagating factor contributing to accelerated atherosclerosis (English)

1 reference

21 August 2017

0 references

1 reference

5

Cees G M Kallenberg

1 reference

21 August 2017

Hans L A Nienhuis

1

1 reference

21 August 2017

Johanna Westra

2

1 reference

21 August 2017

Andries J Smit

3

1 reference

21 August 2017

Pieter C Limburg

4

1 reference

21 August 2017

Marc Bijl

6

1 reference

21 August 2017

1 May 2009

1 reference

21 August 2017

1 reference

21 August 2017

42

1 reference

21 August 2017

4

1 reference

21 August 2017

302-304

1 reference

The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation

21 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F08916930902831746

Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902831746

The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902831746

C-Reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902831746

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902831746

Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902831746

The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902831746

Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902831746

Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902831746

N(epsilon)-carboxymethyllysine-modified proteins are unable to bind to RAGE and activate an inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902831746

Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902831746

Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902831746

High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902831746

Low levels of sRAGE are associated with increased risk for mortality in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902831746

Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902831746

10.1080/08916930902831746

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference